Kocitaf 50mg/200mg/25mg Tablet is unsafe to work with in patients with liver ailment and may be avoided.This dual-motion system not merely targets the malignant cells directly and also empowers the immune method to be a more Energetic participant in eradicating the disease.At its core, KOCITAF features for a monoclonal antibody, engineered to ackno